Not listed
Decision Date:
June 2017



  • NICE TA480 - for treatment of moderate-to-severe active rheumatoid arthritis. (Decision date  - November 2017)
  • NICE TA543 - for the treatment of active psoriatic arthritis after inadequate response to DMARDS (Decision date - November 2018)
  • NICE TA547 - for moderately to severely active ulcerative colitis. (Decision date  - December 2018)
  • NICE TA735 - for treating juvenile idiopathic arthritis. NHSE commissioned. (Decision date - November 2021)
  • NICE TA920 - for treating active ankylosing spondylitis. ICB commissioned (Decision date - November 2023)


Red Drug Classifications

  • 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
  • 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
  • 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app